Dr. Andrés C. García Montero holds a degree in Biology (1992) from the University of Salamanca (USAL) and obtained his PhD Degree in 1997 at the same university. He was awarded with a “Poste Vert” fellowship for foreign researchers at the Unité 315 (currently UMR1068; “Centre de Cancérologie de Marseille”) of Institut National de la Santé et la Research Medicale (INSERM, Marseille, France), where he worked from 1998 to 2000. He then received a grant to return to Spain where he works at the Cancer Research Center (IBMCC, USAL-CSIC) since 2000.
Today he is tenured R3 Researcher at the Biomedical Research Institute of Salamanca (IBSAL-ISCIII), Assistant Professor at the Department of Medicine and Technical Coordinator of the Spanish National DNA Bank Carlos III (USAL). He is integrated (since 2000) of a research group (recognized as a Consolidated Research Unit by the Regional Government of Castile and Leon) ascribed to the IBMCC, and he is also the current Director of NUCLEUS, Platform of Research Support Services of the USAL. A part from his expertise in biobanking, his current research line is focused in the phenotypic and molecular characterization of Systemic Mastocytosis, an orphan disease in which neoplastic mast cells could play an immunomodulatory role over other cell types of the innate and/or adaptive immune responses of the patients affecting cell microenvironment and disease progression.
Research Keywords & Expertise
Biobanking
Flow Cytometry
Hematologic Malignanci...
mastocytosis
oncogene KIT
Fingerprints
45%
mastocytosis
21%
Flow Cytometry
5%
Biobanking
Short Biography
Dr. Andrés C. García Montero holds a degree in Biology (1992) from the University of Salamanca (USAL) and obtained his PhD Degree in 1997 at the same university. He was awarded with a “Poste Vert” fellowship for foreign researchers at the Unité 315 (currently UMR1068; “Centre de Cancérologie de Marseille”) of Institut National de la Santé et la Research Medicale (INSERM, Marseille, France), where he worked from 1998 to 2000. He then received a grant to return to Spain where he works at the Cancer Research Center (IBMCC, USAL-CSIC) since 2000.
Today he is tenured R3 Researcher at the Biomedical Research Institute of Salamanca (IBSAL-ISCIII), Assistant Professor at the Department of Medicine and Technical Coordinator of the Spanish National DNA Bank Carlos III (USAL). He is integrated (since 2000) of a research group (recognized as a Consolidated Research Unit by the Regional Government of Castile and Leon) ascribed to the IBMCC, and he is also the current Director of NUCLEUS, Platform of Research Support Services of the USAL. A part from his expertise in biobanking, his current research line is focused in the phenotypic and molecular characterization of Systemic Mastocytosis, an orphan disease in which neoplastic mast cells could play an immunomodulatory role over other cell types of the innate and/or adaptive immune responses of the patients affecting cell microenvironment and disease progression.
Well done!
